ODS status(European) due by 2nd June.
Also I'm sure that news will filter through to investors soon both here and elsewhere as analysts and the media become more aware of the link between DNDN and PRR.
I listened to the conference call on Friday and was wondering if anyone took notes on what Martin Rogers said about why Prima had chosen ovarian cancer-I think he showed a slide of the benefits for the company and shareholders of choosing this type of cancer above others-something about the limited types of treatments? I'm not sure since I didn't take any notes.
appreciate any clarification here.
Birdseye
nz herald profiles dndn, page-3
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.010(2.99%) |
Mkt cap ! $501.1M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.5¢ | 32.8¢ | $576.6K | 1.699M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 66582 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 288082 | 23 |
View Market Depth
| Last trade - 14.06pm 15/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |